Human Papillomavirus Vaccinations During the COVID-19 Pandemic in Middle Schools in the Rio Grande Valley of Texas.
Am J Public Health
; 112(9): 1269-1272, 2022 09.
Article
in English
| MEDLINE | ID: covidwho-1951732
ABSTRACT
This quasi-experimental study (a community-based, physician-led human papillomavirus [HPV] education campaign and school-based vaccination program) followed 6481 students at eight Pharr-San Juan-Alamo Independent School District (Rio Grande Valley, Texas) middle schools between August 2016 and March 2021. We describe the successes and challenges experienced during the COVID-19 pandemic. HPV vaccine initiation and completion rates increased 1.29-fold and 1.47-fold, respectively, between June 2019 and March 2021. Between March 2020 and March 2021, 268 HPV vaccine doses were provided through 24 school-based interventions. Our program continued successes seen in increasing HPV vaccination rates and reducing possible HPV-associated cancers. (Am J Public Health. 2022;112(9)1269-1272. https//doi.org/10.2105/AJPH.2022.306970).
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Papillomavirus Infections
/
Alphapapillomavirus
/
Papillomavirus Vaccines
/
COVID-19
Type of study:
Experimental Studies
/
Observational study
Topics:
Vaccines
Limits:
Humans
Country/Region as subject:
North America
Language:
English
Journal:
Am J Public Health
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS